Journal of Kerman University of Medical Sciences

Current Issue

By Issue

By Author

Author Index

Keyword Index

About Journal

Aims and Scope

JKMU Ethical Policies

Indexing and Abstracting

Related Links

FAQ

Peer Review Process

News

Metric

Editorial Policies

Data Sharing Policy

Seroprevalence and Risk Factors of Toxoplasmosis in Female Students from Northwest Iran

Document Type : Short Communication

Authors

1 Student Research Committee, Iran University of Medical Sciences, Tehran, Iran

2 Danesh Pathobiology Laboratory, Maragheh, Iran

3 Department of Parasitology and Mycology, School of Medicine, Shahid Beheshti University of Medical Sciences, Tehran, Iran

4 Infectious Diseases Research Center, Health Institute, Kermanshah University of Medical Sciences, Kermanshah, Iran

5 Department of Parasitology & Mycology, Urmia University of Medical Sciences, Urmia, Iran

6 Vector-borne Diseases Research Center, North Khorasan University of Medical Sciences, Bojnurd, Iran

Abstract

Background: Toxoplasmosis is a significant zoonotic disease caused by the protozoan parasite Toxoplasma gondii. This infection can have dire consequences if it occurs during pregnancy, as it may result in spontaneous abortion or congenital disorders. Using serological methods, we investigated the seroprevalence of Toxoplasma infection in female students of childbearing age and also determined the association between Toxoplasma infection and pregnancy.
Methods: In this cross-sectional study, blood samples were collected from female students of childbearing age from three provinces in northwest Iran who studied at Maragheh University of Medical Sciences. Anti-Toxoplasma IgG and IgM antibodies were identified by ELISA and ELFA methods, and the relationship between Toxoplasma infection, demographic characteristics, and risk factors was evaluated.
Results: The ELISA and ELFA serology test results for measuring IgG and IgM, were similar. One hundred cases (28.73%) were positive for Toxo IgG, and 6 cases (1.72%) were positive for Toxo IgM. The results showed that some risk factors, such as contact with cats and activities, such as agriculture or contact with soil, were significantly (P < 0.05) related to T. gondii seropositivity.
Conclusion: More than 70% of the childbearing-age female students studied in this investigation were susceptible to infection during pregnancy, and the performance of regular serological testing during pregnancy and health education about toxoplasmosis before and after gestation is essential to prevent congenital toxoplasmosis.

Keywords

Main Subjects

References
  1. Webster JP. Dubey, JP Toxoplasmosis of Animals and Humans. BioMed Central; 2010.
  2. Nazari N, Shojaee S, Mohebali M, Teimouri A, Ghadiri K, Raeghi S, et al. Toxoplasma gondii and Neospora caninum in brain tissue of rodents in north-west Iran. Vet Med (Auckl). 2019;10:223-7. doi: 10.2147/vmrr.s224664.
  3. Ahmadpour E, Daryani A, Sharif M, Sarvi S, Aarabi M, Mizani A, et al. Toxoplasmosis in immunocompromised patients in Iran: a systematic review and meta-analysis. J Infect Dev Ctries. 2014;8(12):1503-10. doi: 10.3855/jidc.4796.
  4. Torgerson PR, Mastroiacovo P. The global burden of congenital toxoplasmosis: a systematic review. Bull World Health Organ. 2013;91(7):501-8. doi: 10.2471/blt.12.111732.
  5. Rico-Torres CP, Vargas-Villavicencio JA, Correa D. Is Toxoplasma gondii type related to clinical outcome in human congenital infection? Systematic and critical review. Eur J Clin Microbiol Infect Dis. 2016;35(7):1079-88. doi: 10.1007/ s10096-016-2656-2.
  6. Jalai N, Olfatian Gilan B, Tavasoli A, Tanomand A, Reaghi S. Seroepidemiology of toxoplasmosis among pregnant women referring to health center laboratories of Bojnurd in 2013. J North Khorasan Univ Med Sci. 2014;5(5):1101-5. doi: 10.29252/jnkums.5.5.S5.1101. [Persian ].
  7. Raeghi S, Sedeghi S, Sedeghi S. Prevalence of Toxoplasma gondii antibodies in cats in Urmia, northwest of Iran. J Anim Plant Sci. 2011;21(2):132-4.
  8. Gharavi MJ, Oormazdi H, Roointan ES. A Comparative study on sensitivity and specificity of conventional and unconventional IgG and IgM assays for diagnosis of toxoplasmosis. Iran J Public Health. 2008;37(4):42-5 .
  9. Abdollahian E, Shafiei R, Mokhber N, Kalantar K, Fata A. Seroepidemiological study of Toxoplasma gondii infection among psychiatric patients in Mashhad, northeast of Iran. Iran J Parasitol. 2017;12(1):117-22.
  10. Rahbari AH, Keshavarz H, Shojaee S, Mohebali M, Rezaeian M. IgG avidity ELISA test for diagnosis of acute toxoplasmosis in humans. Korean J Parasitol. 2012;50(2):99-102. doi: 10.3347/kjp.2012.50.2.99.
  11. Tuda J, Adiani S, Ichikawa-Seki M, Umeda K, Nishikawa Y. Seroprevalence of Toxoplasma gondii in humans and pigs in North Sulawesi, Indonesia. Parasitol Int. 2017;66(5):615-8. doi: 10.1016/j.parint.2017.04.011.
  12. Sakikawa M, Noda S, Hanaoka M, Nakayama H, Hojo S, Kakinoki S, et al. Anti-Toxoplasma antibody prevalence, primary infection rate, and risk factors in a study of toxoplasmosis in 4,466 pregnant women in Japan. Clin Vaccine Immunol. 2012;19(3):365-7. doi: 10.1128/cvi.05486-11.
  13. Robert-Gangneux F, Dardé ML. Epidemiology of and diagnostic strategies for toxoplasmosis. Clin Microbiol Rev. 2012;25(2):264-96. doi: 10.1128/cmr.05013-11.
  14. Tavakoli Kareshk A, Keyhani A, Asadi A, Zia-Ali N, Mahmoudvand H, Mohammadi AR. Seroprevalence of Toxoplasma gondii infection among childbearing age women in Kerman city, southeastern Iran. J Parasit Dis. 2016;40(4):1544-7. doi: 10.1007/s12639-015-0724-7.
  15. Zarean M, Shafiei R, Gholami M, Fata A, Rahmati-Balaghaleh M, Kariminik A, et al. Seroprevalence of anti-Toxoplasma gondii antibodies in healthy voluntary blood donors from Mashhad city, Iran. Arch Iran Med. 2017;20(7):441-5.
  16. Rahmati-Balaghaleh M, Hosseini Farash BR, Zarean M, Hatami-Pourdehno S, Mirahmadi H, Jarahi L, et al. Diagnosis of acute toxoplasmosis by IgG avidity method in pregnant women referred to health centers in south-eastern Iran. J Parasit Dis. 2019;43(3):517-21. doi: 10.1007/s12639-019-01120-8.
  17. Mumcuoglu I, Toyran A, Cetin F, Coskun FA, Baran I, AksuN, et al. [Evaluation of the toxoplasmosis seroprevalence in pregnant women and creating a diagnostic algorithm]. Mikrobiyol Bul. 2014;48(2):283-91. doi: 10.5578/mb.7000. [Turkish].
  18. Hatam-Nahavandi K, Calero-Bernal R, Rahimi MT, Pagheh AS, Zarean M, Dezhkam A, et al. Toxoplasma gondii infection in domestic and wild felids as public health concerns: a systematic review and meta-analysis. Sci Rep. 2021;11(1):9509. doi: 10.1038/s41598-021-89031-8.
  19. Borna S, Shariat M, Fallahi M, Janani L. Prevalence of immunity to toxoplasmosis among Iranian childbearing age women: systematic review and meta-analysis. Iran J Reprod Med. 2013;11(11):861-8.
  20. Fallah E, Navazesh R, Majidi J, Kushavar H, Mahdipourzareh N. An epidemiological study of Toxoplasma infection among high-school girls in Jolfa. J Reprod Infertil. 2005;6(3):261-9. [Persian].
  21. Elahian Firouz Z, Kaboosi H, Faghih Nasiri A, Tabatabaie SS, Golhasani-Keshtan F, Zaboli F. A comparative serological study of toxoplasmosis in pregnant women by CLIA and ELISA methods in Chalus city Iran. Iran Red Crescent Med J. 2014;16(4):e15115. doi: 10.5812/ircmj.15115.
  22. Abdi J, Shojaee S, Mirzaee A, Keshavarz H. Seroprevalence of toxoplasmosis in pregnant women in Ilam province, Iran. Iran J Parasitol. 2008;3(2):34-7.
  23. Sadooghian S, Mahmoudvand H, Mohammadi MA, Nazari Sarcheshmeh N, Tavakoli Kareshk A, Kamiabi H, et al. Prevalence of Toxoplasma gondii infection among healthy blood donors in northeast of Iran. Iran J Parasitol. 2017;12(4):554-62.
  24. Mirahmadi H, Mehravaran A, sani Haidari M, Rahmati- Balaghaleh M, Raissi V, Shafiei R. Serological and Molecular Survey of Toxoplasma gondii Infection in Hemodialysis Patients with Chronic Renal Disease in Zahedan, Iran. Journal of Kerman University of Medical Sciences 2021; 28(4): 391- 398. doi: 10.22062/JKMU.2021.91720.
  25. Montoya JG, Liesenfeld O, Kinney S, Press C, Remington JS. VIDAS test for avidity of Toxoplasma-specific immunoglobulin G for confirmatory testing of pregnant women. J Clin Microbiol. 2002;40(7):2504-8. doi: 10.1128/jcm.40.7.2504- 2508.2002.
  26. Pujol-Riqué M, Quintó L, Danés C, Valls ME, Coll O, Moreno A, et al. [Dating anti-Toxoplasma IgM in pregnancy using VIDAS-ELFA methods]. Enferm Infecc Microbiol Clin. 2000;18(6):274-8. [Spanish].
  27. Iqbal J, Khalid N. Detection of acute Toxoplasma gondii infection in early pregnancy by IgG avidity and PCR analysis. J Med Microbiol. 2007;56(Pt 11):1495-9. doi: 10.1099/ jmm.0.47260-0.
  28. Khazaei HA, Bokaeian M, Javadimehr M, Soleimani G, Khazaei A, Narouie B, et al. Seroepidemiology evaluation of Toxoplasma IgG values in women at their marriage age and pathogenesis factors. Life Sci J. 2012;9(4):185-90.
  29. Rouhani S, Raeghi S, Mirahmadi H, Fasihi Harandi M, Haghighi A, et al. Identification of Fasciola spp. in the East of Iran, Based on the Spermatogenesis and Nuclear Ribosomal DNA (ITS1) and Mitochondrial (ND1) Genes. Arch Clin Infect Dis. 2017;12(2):e57283. doi:10.5812/archcid.57283.
  30. Gelaye W, Kebede T, Hailu A. High prevalence of anti- Toxoplasma antibodies and absence of Toxoplasma gondii infection risk factors among pregnant women attending routine antenatal care in two hospitals of Addis Ababa, Ethiopia. Int J Infect Dis. 2015;34:41-5. doi: 10.1016/j.ijid.2015.03.005.
Journal of Kerman University of Medical Sciences
Volume 31, Issue 3
May and June 2024
Pages 153-157
Files
Share
How to cite
Statistics